Cargando…

Association between polymorphism rs11200638 in the HTRA1 gene and the response to anti-VEGF treatment of exudative AMD: a meta-analysis

BACKGROUND: Anti-angiogenesis treatments are the most commonly used treatments for the vision loss caused by exudative age-related macular degeneration (AMD), in which the anti-vascular endothelial growth factor (VEGF) drugs with ranibizumab and bevacizumab are current standard treatments. However,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Ya-li, Chen, Chun-li, Wang, Yi-xiao, Tong, Yao, Fang, Xiao-ling, Li, Lin, Wang, Zhao-yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5480205/ https://www.ncbi.nlm.nih.gov/pubmed/28637435 http://dx.doi.org/10.1186/s12886-017-0487-2

Ejemplares similares

HTRA1 rs11200638 variant and AMD risk from a comprehensive analysis about 15,316 subjects
por: Liu, Ying, et al.
Publicado: (2020)

Association of the HtrA1 rs11200638 Polymorphism with Neovascular Age-Related Macular Degeneration in Indonesia
por: Supanji, Supanji, et al.
Publicado: (2021)

Changes in the OCT angiographic appearance of type 1 and type 2 CNV in exudative AMD during anti-VEGF treatment
por: Faatz, Henrik, et al.
Publicado: (2019)

CRISPR editing demonstrates rs10490924 raised oxidative stress in iPSC-derived retinal cells from patients with ARMS2/HTRA1-related AMD
por: Chang, Ya-Ju, et al.
Publicado: (2023)

Anti-VEGF Treatment Strategies for Wet AMD
por: Kovach, Jaclyn L., et al.
Publicado: (2012)

Disease stability and extended dosing under anti-VEGF treatment of exudative age-related macular degeneration (AMD) — a meta-analysis
por: Garweg, Justus G., et al.
Publicado: (2021)

New Therapies of Neovascular AMD—Beyond Anti-VEGFs
por: Yerramothu, Praveen
Publicado: (2018)

The interplay of oxidative stress and ARMS2-HTRA1 genetic risk in neovascular AMD
por: Lu, Zhi-Gang, et al.
Publicado: (2021)

Association between VEGF-A and VEGFR-2 polymorphisms and response to treatment of neovascular AMD with anti-VEGF agents: a meta-analysis
por: Wu, Mingxing, et al.
Publicado: (2017)

Pharmacogenetics of Complement Factor H Y402H Polymorphism and Treatment of Neovascular AMD with Anti-VEGF Agents: A Meta-Analysis
por: Chen, Guohai, et al.
Publicado: (2015)

Joint effects of polymorphisms in the HTRA1, LOC387715/ARMS2, and CFH genes on AMD in a Caucasian population
por: Francis, Peter J, et al.
Publicado: (2008)

HTRA1 promoter variant differentiates polypoidal choroidal vasculopathy from exudative age-related macular degeneration
por: Ng, Tsz Kin, et al.
Publicado: (2016)

New Therapies of Neovascular AMD beyond Anti-VEGF Injections
por: Gahn, Greggory M., et al.
Publicado: (2018)

Predictive Factors in OCT Analysis for Visual Outcome in Exudative AMD
por: Gamulescu, Maria-Andreea, et al.
Publicado: (2012)

Association of CFH, LOC387715, and HTRA1 polymorphisms with exudative age-related macular degeneration in a northern Chinese population
por: Xu, Yule, et al.
Publicado: (2008)

Intravitreal Combination of Dexamethasone Sodium Phosphate and Bevacizumab in The Treatment of Exudative AMD
por: Vakalis, N., et al.
Publicado: (2015)

MicroRNA signatures in vitreous humour and plasma of patients with exudative AMD
por: Ménard, Catherine, et al.
Publicado: (2016)

Initial Pro Re Nata Brolucizumab for Exudative AMD: The PROBE Study
por: Bilgic, Alper, et al.
Publicado: (2021)

Results of the treatment of patients with exudative AMD during the COVID-19 pandemic()
por: Arruabarrena, C., et al.
Publicado: (2022)

Study protocol on prevalence of non-exudative macular neovascularisation and its contribution to prediction of exudation in fellow eyes with unilateral exudative AMD (EYE-NEON)
por: Thottarath, Sridevi, et al.
Publicado: (2023)

Effect of aflibercept in insufficient responders to prior anti-VEGF therapy in neovascular AMD
por: Fassnacht-Riederle, Heidi, et al.
Publicado: (2014)

Anti-VEGF intervention in neovascular AMD: benefits and risks restated as natural frequencies
por: Clearkin, Louis, et al.
Publicado: (2019)

Ocular Risk Factors for Exudative AMD: A Novel Semiautomated Grading System
por: Marques, João Pedro, et al.
Publicado: (2013)

Negative Regulators of Angiogenesis, Ocular Vascular Homeostasis, and Pathogenesis and Treatment of Exudative AMD
por: Farnoodian, Mitra, et al.
Publicado: (2018)

Swept-Source OCT Angiographic Characteristics of Treatment-Naïve Nonexudative Macular Neovascularization in AMD Prior to Exudation
por: Shen, Mengxi, et al.
Publicado: (2021)

HTRA1 rs11528744, BCRA1 rs9928736, and B3GLCT rs4381465 are associated with age-related macular degeneration in a Chinese population
por: Huang, Guo, et al.
Publicado: (2022)

A serum metabolomics study of patients with nAMD in response to anti-VEGF therapy
por: Gao, Yan, et al.
Publicado: (2020)

Treat and Extend Treatment Interval Patterns with Anti-VEGF Therapy in nAMD Patients
por: Skelly, Adrian, et al.
Publicado: (2019)

Topographical Analysis of the Choriocapillaris Reperfusion After Loading Anti-VEGF Therapy in Neovascular AMD
por: Viggiano, Pasquale, et al.
Publicado: (2022)

The Architecture of Macular Neovascularizations Predicts Treatment Responses to Anti-VEGF Therapy in Neovascular AMD
por: Faatz, Henrik, et al.
Publicado: (2022)

Effect of HtrA1 Polymorphism on Sensitivity to Chemotherapy in Patients with Colon Cancer
por: Yao, Yi, et al.
Publicado: (2020)

HTRA1 synergizes with oxidized phospholipids in promoting inflammation and macrophage infiltration essential for ocular VEGF expression
por: Lu, Zhigang, et al.
Publicado: (2019)

Short-term outcomes of patients with neovascular exudative AMD: the effect of COVID-19 pandemic
por: Borrelli, Enrico, et al.
Publicado: (2020)

Polymorphisms rs2010963 and rs833061 of the VEGF gene in polycystic ovary syndrome
por: Vicente, Anna Luiza Silva Almeida, et al.
Publicado: (2022)

Short-term outcomes of switching anti-VEGF agents in eyes with treatment-resistant wet AMD
por: Batioglu, Figen, et al.
Publicado: (2015)

Incidence of ocular hypertension after intravitreal injection of anti-VEGF agents in the treatment of neovascular AMD
por: Moraru, Andreea, et al.
Publicado: (2017)

Development of an inducible anti-VEGF rAAV gene therapy strategy for the treatment of wet AMD
por: Reid, Christopher A., et al.
Publicado: (2018)

Prevalence of Subclinical CNV and Choriocapillaris Nonperfusion in Fellow Eyes of Unilateral Exudative AMD on OCT Angiography
por: Treister, Alison D., et al.
Publicado: (2018)

Automated large-scale prediction of exudative AMD progression using machine-read OCT biomarkers
por: Rudas, Akos, et al.
Publicado: (2023)

Haplotypes of HTRA1 rs1120638, TIMP3 rs9621532, VEGFA rs833068, CFI rs10033900, ERCC6 rs3793784, and KCTD10 rs56209061 Gene Polymorphisms in Age-Related Macular Degeneration
por: Liutkeviciene, Rasa, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l42r65pah216n7a0jd7bqbmk27